Navigation Links
Mayo Clinic researchers discover and manipulate molecular interplay that moves cancer cells
Date:3/29/2009

JACKSONVILLE, Fla. Based on research that reveals new insight into mechanisms that allow invasive tumor cells to move, researchers at the Mayo Clinic campus in Florida have a new understanding about how to stop cancer from spreading. A cancer that spreads elsewhere in the body, known as metastasis, is the process that most often leads to death from the disease.

In the March 29 online issue of Nature Cell Biology, researchers say that a molecule known as protein kinase D1 (PKD1) is key to the ability of a tumor cell to "remodel" its structure, enabling it to migrate and invade. The researchers found that if PKD1 is active, tumor cells cannot move, a finding they say explains why PKD1 is silenced in some invasive cancers.

During metastasis, invasive cancer cells respond to biological signals to move away from a primary tumor. Multiple research groups at Mayo Clinic in Florida are especially interested in this process. One team, led by cancer biologist Peter Storz, Ph.D., has been investigating a process known as actin remodeling at the leading edge - the most forward point - of these migrating tumor cells.

"The events that reorganize the actin cytoskeleton at the leading edge are complex a multitude of molecules act in concert," Dr. Storz says. "But it appears that PKD1 must be turned off if cancer cells are to migrate."

Actin filaments help make up the cytoskeleton of cells. For cancer cells to move, the actin-based cell structure has to be continually reorganized, Dr. Storz says, and to do this, new actin filaments need to be generated to shift the cell forward.

Dr. Storz' group discovered that PKD1 was critical to this process. The researchers found that PKD1 inhibits another protein known as slingshot, which regulates the severing of existing actin structures so that new actin filaments can be synthesized, an event that is essential for cell movement.

The researchers used methods to deplete tumo
'/>"/>

Contact: Paul Scotti
scotti.paul@mayo.edu
904-953-2299
Mayo Clinic
Source:Eurekalert

Page: 1 2

Related biology news :

1. UC Davis bench-to-bedside research: Promising treatment in clinical trials
2. Alzheimers disease therapeutic prevents long-term damage from TBI in pre-clinical studies
3. Researchers win award for best clinical paper in orthopedic physical therapy
4. ABC publishes monograph on scientific and clinical research of Sinupret
5. Mayo Clinic researchers suspect a novel gene is causing restless legs syndrome in a large family
6. TGen Clinical Research Services at Scottsdale Healthcare and Mayo Clinic study new cancer drug
7. 3 new informatics pilot projects to aid clinical and translational scientists nationwide
8. Genome Medicine: Bridging the gap between research and clinical practice
9. Far-reaching genetics topics to be addressed: 2009 Annual Clinical Genetics Meeting, March 25-29
10. Mayo Clinic: Brain disorder suggests common mechanism may underlie many neurodegenerative diseases
11. TGen, Scottsdale Healthcare, Mayo Clinic study new drug to stimulate immune system of cancer victims

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...he Wildlife Conservation Society says that western...epublic of Congopart of the "mother lode" of more ...ming increasingly threatened by growing humans act...ection of the swamp forests adjacent to the southw...t surveys confirmed that high densities of the gre...
(Date:11/23/2009)...rrent research suggests that a common oral bacteri... report by Nichols et al, "Unique Lipids from a Co... Ligands Capable of Enhancing Autoimmunity," appea...rnal of Pathology . , Multiple sclerosis (MS), a... and spinal cord, affects nearly 1 in 700 people i...
(Date:11/23/2009)... only swine vaccine available for the H1N1 virus h...th the virus. The vaccination marks the first time...ith the pandemic flu., Iowa State University,s H... the vaccine this summer and has been shipping pre...nd Illinois for several weeks., The latest vacci...
Breaking Biology News(10 mins):A year after discovery, Congo's 'mother lode' of gorillas remains vulnerable 2Factors from common human bacteria may trigger multiple sclerosis 2Iowa State researcher produces, ships only H1N1 vaccine available for swine 2Chinese Scientists Develop Database on the Liver 61322 1Elsevier pilots new research tool Reflect in its premier life science journal Cell 10722 1Elsevier pilots new research tool Reflect in its premier life science journal Cell 10722 2Many Kids Feel Threatened in the Classroom 61317 1Many Kids Feel Threatened in the Classroom 61317 2
... UCLA researchers knew - based on two clinical tri...onded well to an experimental targeted therapy, bu...e mechanism behind the response, they would be abl...onalize their treatment accordingly. , Extrapolati...ter scientists uncovered the cascade of molecular ...
... A study forthcoming in the June 2006 issue of Cur...sue: How accurate are men,s suspicions of whether ...studies have suggested that up to 10 percent of fa...ged child, but little is known about how this diff...rnity assessments reflect actual biological patern...
... Scientists have long known that the social insect...ees, and wasps--have an unusual mechanism for sex ...s, while fertilized eggs become females. But the d...alled parthenogenesis) remains a mysterious proces...osome, an essential cellular component that is ord...
Other Biology News:UCLA scientists uncover mechanism of response to targeted therapy 2UCLA scientists uncover mechanism of response to targeted therapy 3Insects that produce males from unfertilized eggs reveal a surprising cellular feat 2Insects that produce males from unfertilized eggs reveal a surprising cellular feat 3
(Date:11/20/2009)... , , , , , , , ... A team of scientists from Washington Universit...ring Harbor Laboratory and Iowa State University h... , Click here for more information.... , , , , , , , ...
(Date:11/20/2009)...ov. 20 Novavax, Inc. (Na...n underwritten public offering of 6,800,000 shares...3.30 per share. The approximately $21 million of ...counts and commissions, will be used for preclinic...ccines, internal research and development programs...
(Date:11/20/2009)...LER TOLEDO recently announced that Dr. Dominique H...le of Process Analytical Technology (PAT) in Green...r 1, 2009. , (PRWEB) Nove...nalytical Technology (PAT) in Green Chemistry and ...Analytical Technology (PAT) case studies will be p...
(Date:11/19/2009).... 19 Dr. Mate Hidvegi, inventor of...a press release issued on November 17 by Biropharm...ng false and self-serving statements about its U.S...egi stated from his office in Budapest, Hungary: ...r does not apply to AveULTRA, www.aveultra.com ...
Breaking Biology Technology:Amaizing: Corn genome decoded 2Amaizing: Corn genome decoded 3Amaizing: Corn genome decoded 4Novavax Prices Public Offering of Common Stock 2Process Analytical Technology (PAT) in Green Chemistry and Green Engineering 2American BioSciences Rebuts Misleading Statements Made by Hungarian Competitor 2
... Kan., Nov. 20 KansasBio announced today a,biosci...region,s human,health-care-related bioscience comp...nuum. Called the National Drug Development Acceler...panies across Kansas and the Kansas,City metropoli...rred resources,for drug development. , Kansa...
...H MEETING, Pa., Nov. 20 BMP Sunstone,Corporation ...) today announced,that its wholly-owned subsidiary...nstone"), has signed an agreement to acquire "Runc...) used to treat constipation. Sunstone will also,...tion line, as well as,related LFHC technology from...
...Neb., Nov. 20 Transgenomic,(OTC Bulletin Board: T...ase I,Small Business Innovation Research (SBIR) aw...pport the development of its proposed SURVEYOR,End...ogy. A cost-effective and,high throughput enabling...dentify DNA variations between a reference genome ...
Other Biology Technology:National Drug Development Accelerator Launched 2BMP Sunstone Acquires 'Runchang Capsule' and Related LFHC Technology 2BMP Sunstone Acquires 'Runchang Capsule' and Related LFHC Technology 3Transgenomic Awarded SBIR Grant to Support Development of SURVEYOR(R) Endonuclease Adaptor-ligated Libraries (SEAL) for Determining Whole Genome Sequence Variation 2Transgenomic Awarded SBIR Grant to Support Development of SURVEYOR(R) Endonuclease Adaptor-ligated Libraries (SEAL) for Determining Whole Genome Sequence Variation 3
...These extended-length microarrays are custom desig...onfigurations are available: 8,455 features per ar...res per array (1 array/slide). Features 60-me...ngth delivers higher sensitivity compared to tradi...
...Chemicon Select Tissue Arrays are intended for lab... were fixed in neutral buffered formalin and embed...sis was performed by certified pathologists. Tiss...nd relocated into a new recipient paraffin block, ...
...Chemicon Select Tissue Arrays are intended for lab... were fixed in neutral buffered formalin and embed...sis was performed by certified pathologists. Tiss...nd relocated into a new recipient paraffin block, ...
...MicroVigene is the one mouse-click image analysis ...ein/antibody. It is the solution for high quality ...ne is empowered with VigeneTechs robust algorithms...-curve fitting background correction and dust remo...
Biology Products: